Abstract
Chronic inflammatory demyelinating polyneuropathy (CIDP) is immune-mediated neuropathy defined by clinical progression for more than 2 months, and electrodiagnostic evidence of peripheral nerve demyelination. However, there are several clinical phenotypes, classified into “typical CIDP,” and “atypical CIDP” such as “multifocal acquired demyelinating sensory and motor neuropathy (MADSAM).” Typical CIDP is a most common form, characterized by symmetric proximal and distal muscle weakness and motor-dominant manifestation. In typical CIDP, demyelination predominantly affects the distal nerve terminals and nerve roots, where the blood–nerve barrier is anatomically deficient. These features suggest antibody-mediated demyelination in typical CIDP. By contrast, MADSAM is characterized by multifocal demyelination in the nerve trunks, and such distribution of lesions results in multiple mononeuropathy or asymmetric polyneuropathy. In MADSAM, cellular immunity is likely to be involved in the breakdown of the blood–nerve barrier at the site of conduction block. Clinical features are probably determined by the distribution of demyelinative lesions and reflect the different immunopathogenesis of each CIDP subtype that would require different treatment strategy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ad Hoc Subcommittee for the American Academy of Neurology AIDS Task Force (1991) Research criteria for chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 41:617–618
Barohn RJ et al (1989) Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 46:878–884
Bostock H, Rothwell JC (1997) Latent addition in motor and sensory fibres of human peripheral nerve. J Physiol 498:277–294
Bostock H et al (1994) Differences in behaviour of sensory and motor axons following release of ischaemia. Brain 117:225–234
Bromberg MB, Albers JW (1993) Patterns of sensory nerve conduction abnormalities in demyelinating and axonal peripheral nerve disorders. Muscle Nerve 16:262–266
Dalakas MC et al (2009) Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy. Ann Neurol 65:286–293
Duggins AJ et al (1999) Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain 122:1383–1390
Dyck PJ et al (1975) Chronic inflammatory demyelinating polyradiculoneuropathy. Mayo Clin Proc 50:621–637
Hara M et al (2010) Effect of motor imagery and voluntary muscle contraction on the F wave. Muscle Nerve 42:208–212
Isose S et al (2009) Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies. J Peripher Nerv Syst 14:151–158
Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. (2005). Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 10:220–228 and Eur J Neurol 13:326–332
Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy (2010) Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – First Revision. J Peripher Nerv Syst 15:1–9
Kaku DA et al (1994) Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain 117:941–947
Katz JS et al (2000) Distal acquired demyelinating symmetric neuropathy. Neurology 54:615–620
Kuwabara S (2007) The blood-nerve barrier and sensory nerve conduction. Clin Neurophysiol 118:1901–1902
Kuwabara S, Misawa S (2004) Axonal ionic pathophysiology in human peripheral neuropathy and motor neuron disease. Curr Neurovasc Res 1:373–379
Kuwabara S, Misawa S (2011) Chronic inflammatory demyelinating polyneuropathy: clinical subtypes and their correlation with electrophysiology. Clin Exp Neuroimmunol 2:41–48
Kuwabara S et al (1997) Magnetic resonance imaging at the demyelinative foci in chronic inflammatory demyelinating polyneuropathy. Neurology 48:874–877
Kuwabara S et al (2002) Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 72:37–42
Kuwabara S et al (2015) Different electrophysiological profiles and treatment response in ‘typical’ and ‘atypical’ chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 86:1054–1059
Mathey EK et al (2015) Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. J Neurol Neurosurg Psychiatry 86:973–985
McCombe PA et al (1987) Chronic inflammatory demyelinating polyradiculoneuropathy. Brain 110:1617–1630
Olsson Y (1990) Microenviroment of the peripheral nervous system under normal and pathological conditions. Crit Rev Neurobiol 5:265–311
Saperstein DS et al (1999) Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve 22:560–566
Sghirlanzoni A et al (2000) Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients. Neurol Sci 21:31–37
Shibuya K et al (2015) Reconstruction magnetic resonance neurography in chronic inflammatory demyelinating polyneuropathy. Ann Neurol 77:333–337
Simmons Z et al (1993) Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy. Neurology 43:2202–2209
Stanton M et al (2006) Dispersion of compound muscle action potential in hereditary neuropathies and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 34:417–422
Taniguchi S et al (2008) Effect of motion imagery to counter rest-induced suppression of F-wave as a measure of anterior horn cell excitability. Clin Neurophysiol 119:1346–1352
Tazawa K et al (2008) Spinal nerve root hypertrophy on MRI: clinical significance in the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy. Intern Med 47:2019–2024
Thaisetthawatkul P et al (2002) Dispersion of distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology 59:1526–1532
Yuki N, Kuwabara S (2007) Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology. J Peripher Nerv Syst 12:238–249
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kuwabara, S., Misawa, S. (2019). Chronic Inflammatory Demyelinating Polyneuropathy. In: Sango, K., Yamauchi, J., Ogata, T., Susuki, K. (eds) Myelin. Advances in Experimental Medicine and Biology, vol 1190. Springer, Singapore. https://doi.org/10.1007/978-981-32-9636-7_21
Download citation
DOI: https://doi.org/10.1007/978-981-32-9636-7_21
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-32-9635-0
Online ISBN: 978-981-32-9636-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)